Essex Woodlands Management, Inc. Long-Term Concentrated

CIK: 0001542339 · Show all filings

Period: Q1 2021 (← Previous) (Next →)

Filing Date: May 14, 2021

Total Value ($000): $639,696 (100.0% shares, 0.0% debt)

Holdings (9)

MDXG MIMEDX GROUP, INC. 37.6%

Value ($000) $240,779 Shares 23,376,623 Est. Cost $7.34 Unrealized +31.6%

BVS BIOVENTUS 28.9%

Value ($000) $184,838 Shares 12,096,702 Est. Cost $14.24 Unrealized 0.0%

— REVANCE THERAPEUTICS INC 12.1%

Value ($000) $77,141 Shares 2,759,950 Est. Cost $31.50 Unrealized —

EYPT EYEPOINT PHARMACEUTICALS INC 6.7%

Value ($000) $42,580 Shares 4,190,921 Est. Cost $4.68 Unrealized +140.4%

AXGN AXOGEN INC 5.6%

Value ($000) $35,652 Shares 1,759,699 Est. Cost $4.01 Unrealized +393.0%

— VENUS CONCEPT, INC. 4.6%

Value ($000) $29,182 Shares 12,417,856 Est. Cost $4.17 Unrealized —

TELA TELA BIO, INC. 3.7%

Value ($000) $23,543 Shares 1,580,089 Est. Cost $12.94 Unrealized +16.3%

MNOV MEDICINOVA INC 0.9%

Value ($000) $5,585 Shares 1,105,941 Est. Cost $2.95 Unrealized +97.2%

— CATALYST BIOSCIENCES INC 0.1%

Value ($000) $396 Shares 78,622 Est. Cost $7.36 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
MDXG	MIMEDX GROUP, INC.	23,376,623	$240,779	37.6%	$7.34	+31.6%	COM	602496101
BVS	BIOVENTUS	12,096,702	$184,838	28.9%	$14.24	0.0%	COM CL A	09075A108
—	REVANCE THERAPEUTICS INC	2,759,950	$77,141	12.1%	$31.50	—	COM	761330109
EYPT	EYEPOINT PHARMACEUTICALS INC	4,190,921	$42,580	6.7%	$4.68	+140.4%	COM NEW	30233G209
AXGN	AXOGEN INC	1,759,699	$35,652	5.6%	$4.01	+393.0%	COM	05463X106
—	VENUS CONCEPT, INC.	12,417,856	$29,182	4.6%	$4.17	—	COM	92332W105
TELA	TELA BIO, INC.	1,580,089	$23,543	3.7%	$12.94	+16.3%	COM	872381108
MNOV	MEDICINOVA INC	1,105,941	$5,585	0.9%	$2.95	+97.2%	COM NEW	58468P206
—	CATALYST BIOSCIENCES INC	78,622	$396	0.1%	$7.36	—	COM NEW	14888D208